MGH COVID-19 study data
Researchers from the MGH have measured over 1400 proteins in 306 COVID-19 patients and 78 control subjects. In collaboration with Olink, the protein data and some associated clinical data are now being made available to the wider research community.
- Largest-scale proteomics study to date on COVID-19 samples
- Carried out using Olink Explore 1536, Olink's new PEA platform with NGS readout
- Read more about Olink Explore
Interested in this technology?
If you are interested in learning more about our Olink Explore protein biomarker discovery platform (including discounts for running COVID-19 studies), please contact us using the button below: